Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Gene Therapy Trial for X-CGD With a SIN Gammaretroviral Vector

NCT01906541 is registered in ClinicalTrials.gov with Hubert Serve, Prof., MD as lead sponsor.

NCT NCT01906541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01906541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Gene Therapy Trial for X-CGD With a SIN Gammaretroviral Vector
Lead sponsor
Hubert Serve, Prof., MD
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2013
Completion date
December 31, 2019
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked chronic granulomatous disease